False Claims Act Update & Alert
	Taxpayers Against Fraud Education Fund | Washington, D.C. | WWW.TAF.ORG           June 3, 2009
	.
	.
		Subscribe to this FREE Newsletter Enter your Email Powered by FeedBlitz n TAF Home Page n Previous Newsletters n Email editor   Please take a moment to forward this FREE electronic newsletter to others that might be interested!	Aventis Settles for $95.5 Million Aventis (now Sanofi-aventis) has agreed to pay $95.5 million to settle charges the company knowingly cheated Medicaid by overcharging for anti-inflammatory nasal sprays.  Aventis sold the nasal spray to Kaiser Permanente for less than it sold it to Medicaid -- a violation of Medicaid best price rules.  >> To read more
			Pogue Case Against Healthways Settles for $40 Million It took 15 years, but A. Scott Pogue's whistleblower case against Healthways and the Diabetes Treatment Centers of America, has finally been settled for $40,000,000 in damages and fees. The case was initiated in June 1994, and was not joined by the Federal Government, but Uncle Sam will, nonetheless, be collecting many million of dollars  thanks to a hardworking legal team and a tenacious whistleblower.  >> To read more
			Crooks Worry About Tougher FCA The National Law Journal notes that companies that defraud the government, and the lawyers trying to defend them, are worried that the False Claims Act and the U.S. Department of Justice now have sharper tools for going after fraudsters. The article quotes TAF President Jeb White along with TAF members Shelley Slade and Peter Chatfield.  >> To read more
			Senator Charles Grassley on Bipartisan Support for Amendments to the False Claims Act
			Documents Show AstraZeneca Marketed Seroquel Off-label A strategy document emailed around AstraZeneca in February 2001 said that in "2001 communications will focus on increasing the existing off-label usage of Seroquel in [bipolar disorder], estimated to account for around 20 per cent of current prescriptions and growing strongly."  Other documents released in a document dump by lawyers show that David Brennan, then head of AstraZeneca's US business, and now CEO of the company, knew that salesmen were targeting doctors in order to encourage them to sell the powerful atypical antipsychotic for use in children, despite the fact that Seroquel has never been approved for use by minors. >> To read more
			URS Unit Pays $1.7 Million EG&G Technical Services Inc, a subsidiary of URS Corp., has agreed to pay $1.7 million for double-billing the U.S. Air Force for aircraft parts and services.  >>To read more
			Alabama Hits Hard The State of Alabama has settled six Average Wholesale Price fraud cases for $89 million.  So far, Alabama has won jury verdicts totaling over $352 million in AWP cases, while bringing in over $123 million in AWP settlements.  The state is moving to trial against 45 other drug makers, with the Watson Pharmaceuticals case to begin on June 22nd. >> To read more .
			.....